Register Login

Harmony Biosciences (HRMY)

(30% Negative) HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) Announces Delay in well Trials for future growth Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Oct. 23, 2025, 12:17 p.m.

    📋 HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) - Clinical Trial Update

    Filing Date: 2025-10-23

    Accepted: 2025-10-23 08:15:12

    Event Type: Clinical Trial Update

    Event Details:

    Harmony Biosciences (HRMY) Announces Clinical Trial Update Harmony Biosciences (HRMY) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: well, patients
    • Diseases/Conditions: future growth
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Regulatory Process
    • Collaboration: WAKIX
    • Updated Timeline: October 23, 2025, Tuesday, November 4th, 2025

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Harmony Biosciences
    • CIK: 0001802665
    • Ticker Symbol: HRMY
    • Period End Date: 2025-10-23
    • Document Type: 8-K

Search

News categories